|
⚲
|
| Keyboard |
| Karen Liu | |
|---|---|
| Firm | |
| Address | 3030 Callan Road Suite 200 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Oncoimmune Inc | 021-364168 | Director | 3.0 M of 3.0 M |
||
| Apexigen Inc | 021-355331 | Director | 45.8 M of 70.0 M |
||
| Ansun Biopharma Inc | 021-348287 | Director | 100.0 M of 100.0 M |
||
| Refuge Biotechnologies Inc | 021-325398 | Director | 3.0 M of 3.0 M |
||
| Refuge Biotechnologies Inc | 021-312285 | Director | 10.0 M of 25.0 M |
||
| Aravive Biologics Inc | 021-291420 | Director | 0.4 M of 0.4 M |
||
| Oncoimmune Inc | 021-280152 | Director | 5.5 M of 15.0 M |
||
| Kaiwu Walden Capital LP | 021-183529 | Director | 98.0 M of 150.0 M |
||
| Crown Bioscience Inc | 021-159173 | Director | 30.5 M of 32.2 M |
||
| Activate Systems Inc | 021-131931 | Executive Officer | 0.7 M of 1.0 M |
||